Your browser doesn't support javascript.
loading
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
Rosenberg, Jonathan E; Hahn, Noah M; Regan, Meredith M; Werner, Lillian; Alva, Ajjai; George, Saby; Picus, Joel; Alter, Robert; Balar, Arjun; Hoffman-Censits, Jean; Grivas, Petros; Lauer, Richard; Guancial, Elizabeth A; Hoimes, Christopher; Sonpavde, Guru; Albany, Constantine; Stein, Mark N; Breen, Tim; Jacobs, Cindy; Anderson, Kirsten; Bellmunt, Joaquim; Lalani, Aly-Khan A; Pal, Sumanta; Choueiri, Toni K.
Afiliación
  • Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hahn NM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Regan MM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Werner L; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Alva A; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
  • George S; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Picus J; Siteman Cancer Center, Washington University, St. Louis, MO, USA.
  • Alter R; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Balar A; New York University Perlmutter Cancer Center, New York, NY, USA.
  • Hoffman-Censits J; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA.
  • Grivas P; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Lauer R; University of New Mexico Cancer Center, Albuquerque, NM, USA.
  • Guancial EA; University of Rochester Wilmot Cancer Institute, Rochester, NY, USA.
  • Hoimes C; University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Sonpavde G; University of Alabama Comprehensive Cancer Center, Birmingham, AL, USA.
  • Albany C; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
  • Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Breen T; Hoosier Cancer Research Network, Indianapolis, IN, USA.
  • Jacobs C; OncoGenex Pharmaceuticals, Inc., Bothell, WA, USA.
  • Anderson K; OncoGenex Pharmaceuticals, Inc., Bothell, WA, USA.
  • Bellmunt J; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lalani AA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pal S; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA. Toni_Choueiri@DFCI.HARVARD.EDU.
Br J Cancer ; 118(11): 1434-1441, 2018 05.
Article en En | MEDLINE | ID: mdl-29765151
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Urológicas / Proteínas de Choque Térmico HSP27 / Docetaxel Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Urológicas / Proteínas de Choque Térmico HSP27 / Docetaxel Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos